Roferon-A, Interferon alfa-2a recombinant, injectable solution 0.5mL

Description (Brief)
Roferon-A is an injectible, recombinant pharmaceutical used to treat different types of leukemia, malignant melanoma, multiple myeloma, non-Hodgkin's lymphoma, AIDS-related sarcoma, and hepatitis. It was discontinued in October 2007, as new therapies for the diseases it treated were developed.
Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human interferon are inserted into bacteria. Interferon is a substance that is naturally made by the body to fight infections and tumors. Bacteria produce the interferon, which is harvested and used as the active ingredient in Roferon-A.
Object consists of a sealed white cardboard box with red and black printing. Box contains one multiple-dose vial.
Currently not on view
Object Name
Hoffmann-La Roche
Roche Laboratories
Physical Description
interferon alfa-2a, recombinant, 3 million IU per 0.5mL (drug active ingredients)
overall: 2 11/16 in x 3 1/4 in x 2 in; 6.82625 cm x 8.255 cm x 5.08 cm
overall: 2 3/4 in x 3 1/4 in x 2 in; 6.985 cm x 8.255 cm x 5.08 cm
place made
United States: New Jersey, Nutley
ID Number
accession number
catalog number
See more items in
Medicine and Science: Medicine
Recombinant Pharmaceuticals
Science & Mathematics
Biotechnology and Genetics
Health & Medicine
Data Source
National Museum of American History, Kenneth E. Behring Center


Add a comment about this object